Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease Read more
ReCode Therapeutics Announces Strategic Collaboration with AskBio to Explore Single Vector Gene-Editing Platform Read more
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies Read more
AskBio Announces Strategic Collaboration with ReCode Therapeutics to Explore Single Vector Gene Editing Platform Read more
Nirsevimab US regulatory submission accepted for the prevention of RSV lower respiratory tract disease in infants and children up to age 24 months Read more
Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform Read more
FDA Approves LEQEMBI (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer’s Disease Read more
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets Read more